Arcus Biosciences (RCUS) Revenue Growth (5y) (2022 - 2026)
Arcus Biosciences (RCUS) Revenue Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.44% |
| Dec 31, 2025 | 28.31% |
| Sep 30, 2025 | -16.62% |
| Jun 30, 2025 | 146.73% |
| Mar 31, 2025 | 74.11% |
| Dec 31, 2024 | 21.67% |
| Sep 30, 2024 | 93.93% |
| Jun 30, 2024 | 86.04% |
| Mar 31, 2024 | 141.92% |
| Dec 31, 2023 | 55.06% |
| Sep 30, 2023 | 49.46% |
| Jun 30, 2023 | 87.54% |
| Mar 31, 2023 | 82.06% |
| Dec 31, 2022 | 93.60% |
| Sep 30, 2022 | 189.24% |